 |
Stable Transfection |
|
Transient and Stable Transfection
Capability to integrate genes into the full DNA sequence of a mammalian cell has a significant impact on biomedical research. Transfected genetic material can be expressed in the target cells either transiently or permanently depending on the methods utilized and the experimental questions being investigated. Transient transfections are used most commonly to analyze the short term impact of altered gene or protein expression. Plasmid DNA (pDNA), messenger RNA (mRNA), short interfering RNA (siRNA), and microRNA (miRNA), are introduced and gene products are expressed in the target cells however the nucleic acids do not integrate into the host cell genome. Therefore, gene product expression is transient and typically results in high expression levels that persist for 24-72 hours when RNA is transfected, or 48-96 hours following DNA transfection. Conversely, in order to analyze the long term impact of altered gene or protein expression investigators typically utilize stable transfection protocols to develop stable cell lines. In a subpopulation of transfected cells, whether the desired effect is a stable or transient transfection, the transfected genetic material will integrate into the genome. In order to create stable cell lines, investigators will take advantage of this natural occurrence, and introduce the gene of interest along with a selectable marker. Therefore growth of transfected cells, in the presence of a selecting agent, will enable the subpopulation of cell where the exogenous genetic material has been incorporated into the genome to persist while the remaining cells undergo selection. Utilizing this method, investigators are able to develop cells that permanently express specific genes through their incorporation in the cellular genome. Altogen Custom Services offer generation of stable cell lines by transforming your cell line to stably express vector or gene of interest.
 |
Transfection Resource |
|
siRNA Transfection | Transfection Methods | Stable Transfection | RNAi | siRNA Library Screening | RNAi Therapeutics | Cell Transfection | In Vivo Transfection Reagents | Cell Line Specific Transfection Reagents
 |
Featured Products |
|
In Vivo Transfection Reagents | Fibroblast Cells Transfection Reagent | Astrocyte Cells Transfection Reagent | HEK-293 Transfection Reagent | MEF Transfection Reagent | HepG2 Transfection Reagent | CHO Reagent | MDA-MB Transfection Reagent | Cos7 Transfection Reagent | A549 Transfection Reagent | NIH3T3 Reagent | HUVEC Transfection Reagent | LNCaP Transfection Reagent | MCF-7 Transfection Reagent | PC-12 Reagent
 |
Altogen Biosystems |
|
Altogen Biosystems is a life sciences company dedicated to the development, marketing and manufacture of cell type specific transfection reagents. Efficient delivery of DNA, RNA, siRNA, and microRNA enabled by advanced formulation of reagents and peculiar design of protocols.
Altogen Biosystems offers a complete transfection system for a broad range of cell lines. All reagents are functionally tested to be highly reproducible, serum compatible, induce low toxicity, and can be used for co-transfection experiments, and high throughput applications.
|